(no title)
suryong | 3 years ago
There was study on a drug what is now called Everolimus (mTOR inhibitor) and it showed that it increases the influenza vaccine effectiveness on elderly people https://pubmed.ncbi.nlm.nih.gov/25540326/
The dog aging study is ongoing and they are conducting double-blind placebo controlled trial for rapamycin on dogs. https://newsroom.uw.edu/news/tech-entrepreneurs-pledge-25-mi...
Some smaller scale study on rapamycin for dogs: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411365/
I just don't think there is any compound currently that is more promising than rapamycin, so that's why I mentioned it here.
The most promising future treatment seems to do with cellular reprogramming as it increasingly looks like epigenetic alterations are responsible for a large part of aging, the epigenetic drift theory of aging. https://www.nature.com/articles/s41580-019-0204-5
Good video about epigenetic drift theory by Vera Gorbunova from University of Rochester. https://youtu.be/FhfXP_MX0U4?t=639
The current way of doing medicine for the elderly will never work simply because of ageing, it is like trying to bail water from a sinking ship without fixing the hole. Will work for a short while until it doesn't. I am also very skeptical of getting a working treatment for diseases like Alzheimer's disease without intervening in ageing.
Already when I was a teenager I realized that treating ageing is the holy grail of medicine and it seems recently this field is gaining more attention, but realistically it will be decades in minimum until we get some more radical treatments, might be even longer. At least the billionaires have realized that there is not much point being a billionaire if your body is breaking apart.
All we have now is lifestyle choices, possibly some medicine like rapamycin, and just hoping we don't get unlucky. Worrying trend is also people taking HGH for anti-aging but in the lab it seems to have complete opposite effect, it actually seems more like ageing accelerator.
eesmith|3 years ago
> it showed that it increases the influenza vaccine effectiveness
I was asking about lifespan increase, which was your point, not secondary effects.
> The dog aging study is ongoing
Which I already mentioned, and it's linked-to in my earlier comment.
> Some smaller scale study on rapamycin for dogs
Yes - it's literally the same paper I already mentioned in my earlier comment.
> more promising than rapamycin
The question I asked was: If it's only flies and (most) mice, is that really enough to call it "promising" in humans?
Not the comparative "which is the most promising of the many compounds which have been reported to increase mouse lifespan?"
> Rapamycin consistently shows effect
Really? You write that after my comment, where I quoted how "five studies that have reported either no effect or reduced lifespan when treated with rapamycin" and provided the citation that shows your assertion to be incorrect?